Allurion Technologies Azioni (NYSE: ALUR)

Ultime notizie per Allurion Technologies (NYSE:ALUR) Azioni

Allurion Technologies

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies Inc

Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 1.420455 shares of common stock at an exercise price of $8.10 per share of common stock

WIIM

MDAI

Spectral AI shares are trading higher after the company announced it submitted a De Novo 510k marketing clearance application to the FDA for its DeepView System.

CSAI

Cloudastructure shares are trading higher after Maxim Group initiated coverage on the stock with a Buy rating and announced a price target of $6.

ALOT

AstroNova shares are trading higher. The company announced new senior leadership changes for its CEO and president.

UBS analyst Robin Farley maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Neutral and lowers the price target from $29 to $23.

News

Price Target

Analyst Ratings

NCLH

UBS Maintains Neutral on Norwegian Cruise Line, Lowers Price Target to $23

In a move that will help satisfy increasing demand for globally diversified fixed income solutions, BlackRock launched the iShares Global Government Bond USD Hedged Active ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGOV#NYSE">GGOV</a>), the industry&#8217;s first and only<a href="https://www.benzinga.com/etfs"> actively managed ETF</a> providing USD-hedged exposure to global government bonds.
The fund is billed as a game changer for fixed-income investors who wish to lower risk and pursue higher yields overseas, minus the headache of currency risk.
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/06/46157240/runway-ready-can-aviation-safety-tech-be-the-next-frontier-for-aerospace-etfs">Runway Ready: Can Aviation Safety Tech Be The Next Frontier For Aerospace ETFs?</a>
The fund carries an expense ratio of 0.39%, and follows the Bloomberg Global Treasury USD Hedged Index as its benchmark.
Tom Becker, lead portfolio manager of GGOV, explained that USD-hedged global government bonds in the past have returned more with less volatility than similar U.S.-only bond indices. 
&#8220;We believe that GGOV will be an important tool for many U.S. asset allocators in the current environment of elevated inflation, large budget deficits, and rising issuance,&#8221; he added.
<h1 class="wp-block-heading">What Makes GGOV Different?</h1>
The ETF aims to solve an expanding sore point: overexposure to long-dated U.S. Treasuries, which most investors view as increasingly at risk in the face of fiscal turmoil. GGOV&#8217;s worldwide strategy, underpinned by a currency hedge, aims to increase yields and lower risk when U.S. interest rates outstrip international counterparts.
GGOV comes to the market at the right time when investors are reassessing their bond exposures following global rate changes and ongoing inflation. By blending active alpha creation with a USD hedge, BlackRock is designed to offer both defense and diversification.
GGOV also joins BlackRock&#8217;s growing empire of fixed income ingenuity as the newest member of its $52 billion U.S. active ETF platform and plays a part in its enormous $1 trillion global bond ETF franchise.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/46166959/sp500-stocks-outlook-etf-analysis">This S&amp;P 500 ETF Saw A 30-Month Buying Spree — Now It&#8217;s Over</a></li>
</ul>
Photo: Shutterstock

Bonds

New ETFs

Global

Trading Ideas

ETFs

GGOV

BlackRock Hedges Its Bets — Literally (ETF Included)

Shares of The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) were up by <a href="https://www.benzinga.com/markets/equities/25/06/46165400/boeing-rises-2-8-after-key-trading-signal">almost 6% Friday</a>. But trading on Monday is quiet. The stock has stalled out at an important resistance level.
‘Sell at former peaks' is an old saying on Wall Street. Boeing may prove it to be true once again, like it did earlier this month. This is why we have made it our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
As you can see on the chart below, back in early 2024 Boeing spent a lot of time trading around $215. It was a resistance level. The sellers put a top on it, and then eventually drove it lower. When this happened, a number of traders and investors who bought shares around $215 decided that their decision to do so was a mistake.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="567" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30123319/one12-1024x567.png" alt="" class="wp-image-967272" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30123319/one12-1024x567.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30123319/one12-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30123319/one12-768x425.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30123319/one12.png 1459w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/46166058/elon-musk-birthday-trump-tax-bill-economy">Elon Musk&#8217;s Birthday Wish: Kill The Bill Before It Kills The Economy</a>
Some vowed to hold onto their losing positions. But they also decided that if they could ever do so, they would sell their shares at the same price they paid for them. This would allow them to exit their positions at breakeven.
Because of this, when the stock finally rallied back to $215 earlier this month these traders and investors came into the market as sellers. The large group of orders they placed caused there to be resistance around $215 again.
After the stock sold off of this level for a second time, a similar dynamic occurred.
Some of the people who bought around $215 developed buyer&#8217;s remorse when the price dropped. They also decided to sell if the price returned to their buy price. Now that Boeing has returned to this level, these traders have started to sell.
The large concentration of these sell orders has created resistance again.
‘Sell at former peaks' is a saying based upon the idea that when a stock returns to a price or a level that had previously been a peak or resistance, there is a good chance it hits resistance there again. There's also a good chance a selloff follows.
Shares of Boeing may be about to head lower.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/46171994/emerging-markets-stocks-dollar-outlook">A Weaker Dollar Just Unlocked A Surprise 2025 Winner — And Smart Money Is Moving In</a></li>
</ul>
Image: Shutterstock

Technicals

Stock Of The Day: Will Boeing Prove An Old Wall Street Saying Is True?

BZAI

Blaize Holdings shares are trading higher after the company announced an approximate $56 million contract for its AI platform will be deployed across intelligence surveillance endpoints.

SoFi Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) shares hit a new 52-week high on Monday, capping a period of significant gains in June despite a quiet session for company-specific news. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/SOFI/news">need to know</a>. 
What To Know: The fintech company's shares have been on an upward tear in June, fueled by recent strategic announcements and bullish growth forecasts.
Last week, SoFi <a href="https://www.benzinga.com/markets/tech/25/06/46117473/sofi-stock-gets-supercharged-with-return-to-crypto">revealed</a> its renewed push into the cryptocurrency space, announcing plans to allow members to trade digital assets like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) later this year. The initiative will also include offerings such as crypto-backed loans and international money transfers. 
CEO Anthony Noto emphasized that blockchain innovations would be integrated across all of SoFi's business lines, from investing and borrowing to daily payments.
This latest move builds on the <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46030175/sofi-stock-rises-this-week-amid-bullish-guidance-whats-going-on">strong momentum</a> from earlier in June when executives reaffirmed aggressive growth projections. At the William Blair Growth Stock Conference, CFO Chris Lapointe projected adjusted net revenue to exceed $3 billion by 2025, with annual growth surpassing 25% through 2026.
Analyst Ratings: Analysts have offered a mixed but <a href="https://www.benzinga.com/quote/SOFI/analyst-ratings">generally constructive</a> view on SoFi&#8217;s stock in recent months. On June 2nd, Truist Securities initiated coverage with a Hold rating and a $14 price target. 
This followed a series of updates on April 30th, where Barclays maintained its Equal-Weight rating while raising its price target from $11 to $12. On the same day, UBS held its Neutral rating but increased its price target to a range of $14 to $15.50. Meanwhile, Needham reiterated its Buy rating with a steady $20 price target, suggesting significant upside.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SOFI shares are trading higher by 8.6% to $18.66 Monday morning. The stock has a 52-week high of $18.92 and a 52-week low of $6.01.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/46117473/sofi-stock-gets-supercharged-with-return-to-crypto">SoFi Stock Gets Supercharged With Return To Crypto</a>
<h2 class="wp-block-heading">How To Buy SOFI Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in SoFi Technologies&#8217; case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

$BTC

$ETH

SOFI

SoFi Technologies Stock Hits A New 52-Week High: What's Going On?

BMO Capital analyst John McNulty downgrades Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) from Market Perform to Underperform and lowers the price target from $7 to $3.

Downgrades

TROX

BMO Capital Downgrades Tronox Holdings to Underperform, Lowers Price Target to $3

GRRR

Gorilla Technology Group shares are trading lower after the company initiated a $105 million direct stock offering.

NMAX

Newsmax shares are trading higher amid its inclusion into the Russell 2000 and 3000 indexes.

Citigroup analyst Michael Ward maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Buy and raises the price target from $123 to $136.

Citigroup Maintains Buy on Lear, Raises Price Target to $136

Bank of America Securities analyst Mihir Bhatia noted on Monday that&nbsp;American Express Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) and Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) <a target="_blank" href="https://www.benzinga.com/topic/stress-test" rel="noreferrer noopener">both passed the</a> Federal Reserve Board&#8217;s 2025 Dodd-Frank Supervisory Stress Test (DFAST), the results of which were released after market close on Friday.
The Federal Reserve&#8217;s annual stress test evaluates if banks can withstand severe economic downturns, like a recession, and still operate normally. 
It checks their financial strength by estimating potential losses, revenues, and expenses under hypothetical bad conditions. The test results help the Fed set a Stress Capital Buffer (SCB), a key requirement that ensures banks have enough capital to absorb losses and continue lending.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/46158087/big-banks-pass-feds-2025-stress-test-with-ease-but-some-say-it-was-too-easy" rel="noreferrer noopener">Big Banks Pass Fed&#8217;s 2025 Stress Test With Ease—But Some Say It Was Too Easy</a>
While not seeing the recent stress test results as a major catalyst, Bhatia views them as an &#8220;incremental positive&#8221; for Capital One. This is particularly relevant given Bhatia&#8217;s capital return bull thesis for the financial giant.
Bhatia notes that while the successful stress test outcome for Capital One was largely expected, it nonetheless &#8220;clears a bar.&#8221; Crucially, the lower SCB for Capital One is highlighted as a significant positive for the company&#8217;s prospective capital returns to shareholders.
Bhatia reiterated Buy ratings on both American Express and Capital One following the stress test results.
The analyst said Capital One&#8217;s SCB was down to 4.5% from 5.5% last year, and American Express&#8217;s was unchanged at 2.5% (the minimum).
Capital One&#8217;s results did not surprise him, given a less severe downturn in the 2025 scenario compared to 2024. Bhatia said better results were driven by better revenue performance in the 2025 test.
According to the analyst, under the severely adverse scenario, which assumes a 10% unemployment rate, American Express still produces positive earnings before taxes over the stress test period. Capital One would have negative earnings, he noted.
Bhatia noted that the Federal Reserve estimates that American Express and Capital One&#8217;s company-wide loss rates would be 11.8% and 16.4%, respectively, above last year&#8217;s results of 12.3% and 16.5%.
As per the analyst, the pure-play card issuers have first-quarter 2025 CET1 (Common equity tier 1) ratios +350bps above their minimum regulatory requirements and strong capital positions.
It&#8217;s important to note that these stress test results do not include Discover Financial Services. Capital One recently completed its acquisition of Discover Financial Services on May 18, 2025.
The company is in the process of completing internal stress tests to form its view of its medium-term capital targets, previously around 11%, Bhatia said.
With the closing of this acquisition, Capital One is no longer required to obtain prior approval for its capital choices. The company expects to complete internal stress testing in the second half of 2025, after which Bhatia anticipates a ramp-up in capital returns.
He suggests that Capital One will likely operate with a buffer to its new target during the integration process, implying elevated capital returns for some time rather than a single substantial payout.
For American Express (AXP), currently priced at $317.9, Bhatia forecasts a target price of $353. This projection is based on a 20.5x price-to-earnings (PE) multiple applied to the company&#8217;s anticipated 2026 earnings per share (EPS).
Bhatia justifies this multiple by stating it aligns with the broader market&#8217;s valuation and is further supported by AXP&#8217;s historical valuation trends and a growing confidence in the stability and resilience of its earnings.
Regarding Capital One (COF), which is currently trading at $211.01, Bhatia has set a price forecast of $233. This forecast is calculated using a 10x PE multiple applied to its 2027 EPS forecast, with the valuation then discounted back by one year.
While acknowledging that this 10x PE multiple sits at the higher end of Capital One&#8217;s historical range (which typically fluctuates between 7x and 12x), Bhatia believes it is appropriate.
The justification for this higher multiple stems from anticipated synergy realization from recent acquisitions, an optimistic outlook on credit quality, and the strength of Capital One&#8217;s cardholder base.
Price Actions: AXP stock is up 0.37% at $318.48 at last check Monday. COF is up 1.15%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/06/45791216/citi-to-cut-3500-tech-jobs-in-china-in-global-restructuring-spree" target="_blank" rel="noreferrer noopener">Citi To Cut 3,500 Tech Jobs In China In Global Restructuring Spree</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Reiteration

American Express, Capital One Pass Fed's Stress Test

Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) has outperformed the market over the past 20 years by 2.37% on an annualized basis producing an average annual return of 10.9%. Currently, Williams-Sonoma has a market capitalization of $19.97 billion. 
Buying $100 In WSM: If an investor had bought $100 of WSM stock 20 years ago, it would be worth $787.96 today based on a price of $161.69 for WSM at the time of writing.
<h3>Williams-Sonoma's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751301014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Williams-Sonoma 20 Years Ago Would Be Worth This Much Today

Citigroup analyst Patrick Cunningham maintains Air Products (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Buy and raises the price target from $310 to $320.

Citigroup Maintains Buy on Air Products, Raises Price Target to $320

Live On CNBC, Jim Lebenthal Announces Sold MP Materials

<a href="https://www.axios.com/2025/06/30/trump-tariffs-customs-revenue" title="https://www.axios.com/2025/06/30/trump-tariffs-customs-revenue">https://www.axios.com/2025/06/30/trump-tariffs-customs-revenue</a>

Macro Economic Events

Politics

Economics

General

'Trump Admin Customs Revenue Tops $100 Billion, Boosted By Tariffs' - Axios

Loop Capital analyst Yun Kim maintains Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Buy and raises the price target from $52.5 to $60.

PEGA

Loop Capital Maintains Buy on Pegasystems, Raises Price Target to $60

<a href="https://www.theinformation.com/briefings/temu-resumes-meta-google-ad-spending-u-s" title="https://www.theinformation.com/briefings/temu-resumes-meta-google-ad-spending-u-s">https://www.theinformation.com/briefings/temu-resumes-meta-google-ad-spending-u-s</a>

GOOG

GOOGL

'Temu Resumes Meta, Google Ad Spending in U.S.' - The Information

Barclays analyst Gaurav Jain maintains Smurfit WestRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) with a Overweight and lowers the price target from $64 to $63.

Barclays Maintains Overweight on Smurfit WestRock, Lowers Price Target to $63

Press Releases

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Allurion Announces Postponement of Special Meeting of Stockholders

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

Allurion to Present at Jefferies Global Healthcare Conference

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

Comments

Allurion Technologies

Notizie

Ultime notizie per Allurion Technologies (NYSE:ALUR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO